Dr. Elezaby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2019 - 2023
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2017 - 2019
- Boston University School of MedicineClass of 2017, MD PhD
Certifications & Licensure
- CA State Medical License 2018 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Cardiac troponin I directly binds and inhibits mitochondrial ATP synthase with a noncanonical role in the post-ischemic heart.Aly Elezaby, Amanda J Lin, Vijith Vijayan, Suman Pokhrel, Benjamin R Kraemer
Nature Cardiovascular Research. 2024-08-01 - Extracellular release of damaged mitochondria induced by prehematopoietic stem cell transplant conditioning exacerbates GVHD.Vijith Vijayan, Hao Yan, Juliane K Lohmeyer, Kaylin A Prentiss, Rachna V Patil
Blood Advances. 2024-07-23 - 6 citationsA Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury.Nir Qvit, Amanda J Lin, Aly Elezaby, Nicolai P Ostberg, Juliane C Campos
Pharmaceuticals. 2022-02-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: